| Ticker Details |
|
Erasca, Inc.
|
| IPO Date: |
July 16, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$3.72B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.26 | 4.20%
|
| Avg Daily Range (30 D): |
$0.97 | 6.82%
|
| Avg Daily Range (90 D): |
$0.70 | 4.87%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.39M |
| Avg Daily Volume (30 D): |
7.25M |
| Avg Daily Volume (90 D): |
5.39M |
| Trade Size |
| Avg Trade Size (Sh.): |
134 |
| Avg Trade Size (Sh.) (30 D): |
120 |
| Avg Trade Size (Sh.) (90 D): |
110 |
| Institutional Trades |
| Total Institutional Trades: |
1,156 |
| Avg Institutional Trade: |
$2.19M |
| Avg Institutional Trade (30 D): |
$2.06M |
| Avg Institutional Trade (90 D): |
$2.51M |
| Avg Institutional Trade Volume: |
.28M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.4M |
| Avg Closing Trade (30 D): |
$5.94M |
| Avg Closing Trade (90 D): |
$7.85M |
| Avg Closing Volume: |
554.91K |
|
|
| News |
May 30, 2026 @ 12:27 AM
Why This Fund Made a $189 Million Bet on Erasca as...
Source: Jonathan Ponciano
|
May 19, 2026 @ 10:53 PM
ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C....
Source: Bragar Eagel & Squire, P.C.
|
May 14, 2026 @ 9:52 PM
ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C....
Source: Bragar Eagel & Squire, P.C.
|
May 14, 2026 @ 6:31 PM
Why This Hedge Fund Added $29 Million to a Cancer ...
Source: Jonathan Ponciano
|
May 11, 2026 @ 11:00 AM
Erasca Announces Clinical Trial Collaboration and ...
Source: Erasca, Inc.
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-.6
|
$-.1
|
$-.44
|
|
Diluted EPS
|
$-.6
|
$-.1
|
$-.44
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-183.44M
|
$-29.09M
|
$-124.55M
|
|
Operating Income / Loss
|
$-187.91M
|
$-32.6M
|
$-140.91M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-26.55M
|
$3.58M
|
$6.07M
|
|
PE Ratio
|
|
|
|
|
|
|
